JP2022521801A5 - - Google Patents
Info
- Publication number
- JP2022521801A5 JP2022521801A5 JP2021550168A JP2021550168A JP2022521801A5 JP 2022521801 A5 JP2022521801 A5 JP 2022521801A5 JP 2021550168 A JP2021550168 A JP 2021550168A JP 2021550168 A JP2021550168 A JP 2021550168A JP 2022521801 A5 JP2022521801 A5 JP 2022521801A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- fluoro
- effective amount
- benzo
- pyrimidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962812002P | 2019-02-28 | 2019-02-28 | |
| US62/812,002 | 2019-02-28 | ||
| PCT/US2020/019884 WO2020176610A1 (en) | 2019-02-28 | 2020-02-26 | Method for treating a multiple myeloma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521801A JP2022521801A (ja) | 2022-04-12 |
| JP2022521801A5 true JP2022521801A5 (enExample) | 2023-03-02 |
Family
ID=72238680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021550168A Pending JP2022521801A (ja) | 2019-02-28 | 2020-02-26 | 多発性骨髄腫を治療するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220143016A1 (enExample) |
| EP (1) | EP3931196A4 (enExample) |
| JP (1) | JP2022521801A (enExample) |
| CN (1) | CN113710670A (enExample) |
| AU (1) | AU2020227748A1 (enExample) |
| BR (1) | BR112021016747A2 (enExample) |
| CA (1) | CA3131249A1 (enExample) |
| EA (1) | EA202192117A1 (enExample) |
| IL (1) | IL285800A (enExample) |
| MX (1) | MX2021010398A (enExample) |
| WO (1) | WO2020176610A1 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH593266A5 (enExample) * | 1973-09-20 | 1977-11-30 | Delalande Sa | |
| EP1351691A4 (en) * | 2000-12-12 | 2005-06-22 | Cytovia Inc | SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCERS, AND USE THEREOF |
| EP2624818B1 (en) * | 2010-10-05 | 2017-04-05 | Fresenius Kabi USA, LLC | Bortezomib formulations stabilised with boric acid |
| PH12015501130B1 (en) * | 2012-11-21 | 2023-01-27 | Ptc Therapeutics Inc | Substituted reverse pyrimidine bmi-1 inhibitors |
| MX370588B (es) * | 2013-08-30 | 2019-12-16 | Ptc Therapeutics Inc | Inhibidores de la bmi-1 de pirimidina sustituida. |
| JP2021535198A (ja) * | 2018-08-17 | 2021-12-16 | ピーティーシー セラピューティクス， インコーポレイテッド | 膵臓癌を治療する方法 |
| KR20210151061A (ko) * | 2019-03-11 | 2021-12-13 | 피티씨 테라퓨틱스, 인크. | 향상된 생체이용률을 갖는 화합물 형태 및 이의 제형 |
-
2020
- 2020-02-26 AU AU2020227748A patent/AU2020227748A1/en not_active Abandoned
- 2020-02-26 BR BR112021016747-1A patent/BR112021016747A2/pt not_active Application Discontinuation
- 2020-02-26 CN CN202080030185.4A patent/CN113710670A/zh active Pending
- 2020-02-26 WO PCT/US2020/019884 patent/WO2020176610A1/en not_active Ceased
- 2020-02-26 EP EP20762789.4A patent/EP3931196A4/en active Pending
- 2020-02-26 JP JP2021550168A patent/JP2022521801A/ja active Pending
- 2020-02-26 US US17/433,106 patent/US20220143016A1/en not_active Abandoned
- 2020-02-26 EA EA202192117A patent/EA202192117A1/ru unknown
- 2020-02-26 CA CA3131249A patent/CA3131249A1/en active Pending
- 2020-02-26 MX MX2021010398A patent/MX2021010398A/es unknown
-
2021
- 2021-08-23 IL IL285800A patent/IL285800A/en unknown